Colasanti Jonathan, Kelly Jane, Pennisi Eugene, Hu Yi-Juan, Root Christin, Hughes Denise, Del Rio Carlos, Armstrong Wendy S
Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine.
Infectious Diseases Program, Grady Health System.
Clin Infect Dis. 2016 Mar 1;62(5):648-654. doi: 10.1093/cid/civ941. Epub 2015 Nov 12.
The human immunodeficiency virus (HIV) care continuum has become an important tool for evaluating HIV care. Current depictions of the care continuum are often cross-sectional and evaluate retention and viral suppression (VS) in a single year, yet the National HIV/AIDS Strategy calls for programs with long-lasting outcomes.
Retrospective chart review of HIV-infected patients enrolled in a large, urban clinic in 2010 followed longitudinally for 36 months. McNemar comparisons and logistic regression analyses were conducted to evaluate covariate association with continuous retention and VS. Generalized estimating equation log-linear models were used to integrate time into the model.
Among 655 patients (77% male, 83% black, 54% men who have sex with men (MSM), 78% uninsured) continuous retention/VS at 12 months (84%/64%), 24 months (60%/48%), and 36 months (49%/39%) showed significant attrition (P < .0001) over time. Continuous retention was associated with prevalent VS at the end of 36 months (adjusted prevalence ratio 3.12; 95% confidence interval [CI], 2.40, 4.07). 12-month retention for black (84%) and nonblack (85%) patients was equivalent, yet fewer blacks (46%) than nonblacks (63%) achieved 36-month continuous retention due to a significant interaction between race and time (aOR 0.75, 95% CI, .59, .95).
Continuous retention is a critically important measure of long-term success in HIV treatment and the crucial component of successful treatment-as-prevention but is infrequently evaluated. Single cross-sections may overestimate successful retention and virologic outcomes. A longitudinal HIV care continuum provides greater insight into long-term outcomes and exposes disparities not evident with traditional cross-sectional care continua.
人类免疫缺陷病毒(HIV)治疗连续过程已成为评估HIV治疗的重要工具。目前对治疗连续过程的描述通常是横断面的,且评估的是单一年度的留存率和病毒抑制情况,然而《国家HIV/艾滋病战略》要求项目具备长期效果。
对2010年在一家大型城市诊所登记的HIV感染患者进行回顾性病历审查,并对其进行为期36个月的纵向跟踪。进行McNemar比较和逻辑回归分析,以评估协变量与持续留存率和病毒抑制之间的关联。使用广义估计方程对数线性模型将时间纳入模型。
在655名患者中(77%为男性,83%为黑人,54%为男男性行为者[MSM],78%未参保),12个月(84%/64%)、24个月(60%/48%)和36个月(49%/39%)的持续留存率/病毒抑制率随时间推移出现显著下降(P <.0001)。持续留存率与36个月末的现患病毒抑制相关(调整后的患病率比为3.12;95%置信区间[CI],2.40,4.07)。黑人(84%)和非黑人(85%)患者的12个月留存率相当,但由于种族与时间之间存在显著交互作用(调整后的比值比为0.75,95%CI,.59,.95),实现36个月持续留存的黑人(46%)少于非黑人(63%)。
持续留存是HIV治疗长期成功的一项至关重要的指标,也是成功治疗即预防的关键组成部分,但很少得到评估。单一横断面研究可能会高估成功留存率和病毒学结果。纵向HIV治疗连续过程能更深入地了解长期结果,并揭示传统横断面治疗连续过程中不明显的差异。